HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synergistic action of alkylating agents and methylxanthine derivatives in the treatment of chronic lymphocytic leukemia.

AuthorsJ L Binet, F Mentz, V Leblond, H Merle-Beral
JournalLeukemia (Leukemia) Vol. 9 Issue 12 Pg. 2159-61 (Dec 1995) ISSN: 0887-6924 [Print] England
PMID8609738 (Publication Type: Letter)
Chemical References
  • Antineoplastic Agents, Alkylating
  • Phosphodiesterase Inhibitors
  • Xanthines
  • Chlorambucil
  • methylxanthine
  • Cyclophosphamide
  • Theophylline
  • Pentoxifylline
Topics
  • Antineoplastic Agents, Alkylating (therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Chlorambucil (administration & dosage)
  • Cyclophosphamide (administration & dosage)
  • Drug Synergism
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell (drug therapy)
  • Pentoxifylline (administration & dosage)
  • Phosphodiesterase Inhibitors (therapeutic use)
  • Theophylline (administration & dosage)
  • Xanthines (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: